Altered human oligodendrocyte heterogeneity in multiple sclerosis

Sarah Jäkel, Eneritz Agirre, Ana Mendanha Falcão, David van Bruggen, Ka Wai Lee, Irene Knuesel, Dheeraj Malhotra, Charles ffrench-Constant, Anna Williams, Gonçalo Castelo-Branco

Abstract

Oligodendrocyte pathology is increasingly implicated in neurodegenerative diseases as oligodendrocytes both myelinate and provide metabolic support to axons. In multiple sclerosis (MS), demyelination in the central nervous system thus leads to neurodegeneration, but the severity of MS between patients is very variable. Disability does not correlate well with the extent of demyelination1, which suggests that other factors contribute to this variability. One such factor may be oligodendrocyte heterogeneity. Not all oligodendrocytes are the same—those from the mouse spinal cord inherently produce longer myelin sheaths than those from the cortex2, and single-cell analysis of the mouse central nervous system identified further differences3,4. However, the extent of human oligodendrocyte heterogeneity and its possible contribution to MS pathology remain unknown. Here we performed single-nucleus RNA sequencing from white matter areas of post-mortem human brain from patients with MS and from unaffected controls. We identified subclusters of oligodendroglia in control human white matter, some with similarities to mouse, and defined new markers for these cell states. Notably, some subclusters were underrepresented in MS tissue, whereas others were more prevalent. These differences in mature oligodendrocyte subclusters may indicate different functional states of oligodendrocytes in MS lesions. We found similar changes in normal-appearing white matter, showing that MS is a more diffuse disease than its focal demyelination suggests. Our findings of an altered oligodendroglial heterogeneity in MS may be important for understanding disease progression and developing therapeutic approaches.

Datasets

1. Oligodendrocytes in MS
Metadata
Sample
Lesion
Clusters_res08
author_cell_types
donor_id
development_stage_ontology_term_id
sex_ontology_term_id
tissue_ontology_term_id
cell_type_ontology_term_id
donor_cause_of_death
suspension_type
assay_ontology_term_id
organism_ontology_term_id
self_reported_ethnicity_ontology_term_id
disease_ontology_term_id
MS_type
MS_duration
tissue_type
cell_type
assay
disease
organism
sex
tissue
self_reported_ethnicity
development_stage
MS122_NAWM2304 cells
CO392029 cells
MS122_CI1843 cells
MS122_A1538 cells
SD48/161361 cells
MS176_NAWM1335 cells
CO141253 cells
CO25991 cells
CO28957 cells
MS121_A2701 cells
MS121_NAWM648 cells
MS121_A3565 cells
MS242_CA5495 cells
MS121_CA478 cells
MS176_RM415 cells
MS176_CA344 cells
MS242_CA2325 cells
MS176_CI78 cells
MS242_CI72 cells
MS242_RM67 cells
Preview
Altered human oligodendrocyte heterogeneity in multiple sclerosis

Analyze this study

Source data

https://cellxgene.cziscience.com/collections/16c1e722-96ae-4bf6-b408-cd7f8918484f

Alias names

Single nuclei RNA- sequencing from the white matter of individuals with progressive MS and non-neurological controls, PMID30747918, PMC6544546, EGAS00001003412, GSE118257

Cite this study

Jäkel, S., Agirre, E., Mendanha Falcão, A., Van Bruggen, D., Lee, K.W., Knuesel, I., Malhotra, D., Ffrench-Constant, C., Williams, A. and Castelo-Branco, G., 2019. Altered human oligodendrocyte heterogeneity in multiple sclerosis. Nature, 566(7745), pp.543-547. https://doi.org/10.1038/s41586-019-0903-2